Nanologica (Sweden) Today
| NICA Stock | 1.82 0.09 5.20% |
Performance0 of 100
| Odds Of DistressOver 64
|
Nanologica is selling for under 1.82 as of the 23rd of November 2024; that is 5.20 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1.72. Nanologica has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Nanologica AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of December 2022 and ending today, the 23rd of November 2024. Click here to learn more.
Moving together with Nanologica Stock
Moving against Nanologica Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nanologica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nanologica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanologica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology (View all Sectors) |
Nanologica AB (NICA) is traded on Stockholm Exchange in Sweden and employs 6 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 367.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanologica's market, we take the total number of its shares issued and multiply it by Nanologica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nanologica AB has 36.15 M outstanding shares.
Nanologica generates negative cash flow from operations
Check Nanologica Probability Of Bankruptcy
Ownership AllocationNanologica AB maintains a total of 36.15 Million outstanding shares. Nanologica AB secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.81 % of Nanologica AB outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nanologica Ownership Details
Nanologica AB Risk Profiles
Although Nanologica's alpha and beta are two of the key measurements used to evaluate Nanologica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.45 | |||
| Standard Deviation | 6.59 | |||
| Variance | 43.37 | |||
| Risk Adjusted Performance | (0.13) |
Nanologica Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nanologica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Nanologica Corporate Management
Elected by the shareholders, the Nanologica's board of directors comprises two types of representatives: Nanologica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanologica. The board's role is to monitor Nanologica's management team and ensure that shareholders' interests are well served. Nanologica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanologica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andreas Bhagwani | Chief Officer | Profile | |
| P Dutta | Sr Chromatography | Profile | |
| Eva Osterman | Chief Officer | Profile | |
| Gary Pitcairn | Chief Officer | Profile | |
| AnnaKarin Renstrm | Chief Officer | Profile | |
| Katarina Alenas | VP Chromatography | Profile |
Additional Tools for Nanologica Stock Analysis
When running Nanologica's price analysis, check to measure Nanologica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanologica is operating at the current time. Most of Nanologica's value examination focuses on studying past and present price action to predict the probability of Nanologica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanologica's price. Additionally, you may evaluate how the addition of Nanologica to your portfolios can decrease your overall portfolio volatility.